News & Articles

The new research describes a minimally invasive and inexpensive blood test that could identify cancer in patients with non-specific symptoms

The novel combination of two nanoparticle-formulated drugs has shown to extend the survival of mice with medulloblastoma

Claim your free compilation of top eBooks, articles, techniques, webinars and videos from our scientific communities

Heparin, a widely available and affordable drug, has been found to limit lung damage when inhaled by COVID-19 patients.

Therapeutic relationships can help improve outcomes for mental health patients

Study findings add to the evidence that vaccination during pregnancy does not increase the risk of complications in pregnancy but COVID-19 does

University of Manchester researchers share findings from a study into the use of locum GPs in England

Findings are an essential first step in understanding the safety and feasibility of using psilocybin as a potential treatment for a range of mental health conditions

A study by experts at King's College London has found that symptoms of early COVID-19 are similar to vaccine side-effects

Study shows people with severe mental illnesses experience significantly poorer outcomes resulting from COVID-19 which are only partly explained by pre-existing physical health conditions

Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?

Both vaccines are highly effective and either one is strongly recommended

Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments

Watch this on-demand webinar to discover novel 3D imaging platforms to enhance the imaging and analysis capabilities of complex 3D structures

Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant

Data are now available from all enrolled participants

A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories

Novel contrast agent is being developed to address the medical need of patients with poor kidney function

Study will assess the immune response of the vaccine which is based on a genetically modified version of a common cold virus

New preclinical data further supports ability of CM-101 to break the vicious cycle of inflammation and fibrosis in primary sclerosing cholangitis

First clinical trial injecting naked mRNA directly into the heart of patients undergoing elective coronary artery bypass surgery

The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)

DAPA-CKD Phase III trial sub-analyses showed that kidney and cardiovascular outcomes were consistent